Orchestra BioMed Holdings, Inc. announced promising echocardiographic data regarding atrioventricular interval modulation (AVIM) therapy's impact on patients with diastolic dysfunction at the THT 2025 ...
Medically reviewed by Jeffrey S. Lander, MDFact checked by Nick BlackmerMedically reviewed by Jeffrey S. Lander, MDFact checked by Nick Blackmer Diastolic dysfunction refers to a cardiac condition ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果